UnitedHealth Group Incorporated $UNH Stock Sold by Ritholtz Wealth Management

Ritholtz Wealth Management lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 20,368 shares of the healthcare conglomerate’s stock after selling 2,037 shares during the period. Ritholtz Wealth Management’s holdings in UnitedHealth Group were worth $7,477,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently added to or reduced their stakes in the business. Nvwm LLC increased its stake in UnitedHealth Group by 89.2% during the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock worth $26,000 after acquiring an additional 33 shares during the last quarter. Wellington Altus USA Inc. raised its position in UnitedHealth Group by 97.1% in the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 33 shares during the period. Security National Bank of SO Dak acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $29,000. Compass Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter worth $29,000. Finally, Aberdeen Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth $31,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. KeyCorp restated an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, October 14th. Deutsche Bank increased their target price on shares of UnitedHealth Group from $370.00 to $467.00 and gave the stock a “hold” rating in a research note on Friday, July 17th. DA Davidson set a $512.00 price target on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Raymond James Financial reissued an “outperform” rating and issued a $450.00 price target on shares of UnitedHealth Group in a research note on Thursday, October 15th. Finally, UBS Group restated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $463.93.

UnitedHealth Group Stock Down 0.5%

Shares of NYSE:UNH opened at $403.14 on Thursday. The firm has a market capitalization of $361.22 billion, a PE ratio of 23.02, a price-to-earnings-growth ratio of 1.47 and a beta of 0.51. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The firm’s 50-day moving average is $391.12 and its two-hundred day moving average is $364.76.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. The business had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter last year, the firm posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be given a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 53.00%.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.19% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.